Clearside Biomedical, Inc., headquartered in Alpharetta, Georgia, specializes in delivering therapies to the back of the eye using a unique suprachoroidal space (SCS) injection platform. The company, which went public in 2016, is developing products like XIPERE and collaborates with partners on other ophthalmic therapies using its SCS Microinjector.
CLSD filed a patent for "systems, devices, and methods for needle-less ocular injections" on Fri, July 15, 2022.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
